JHS Svendgaard Laboratories Limited (JHS.NS)
- Previous Close
14.26 - Open
14.35 - Bid --
- Ask --
- Day's Range
13.80 - 14.35 - 52 Week Range
11.00 - 32.69 - Volume
207,647 - Avg. Volume
122,599 - Market Cap (intraday)
1.226B - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
-- - EPS (TTM)
-1.65 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 26, 2011
- 1y Target Est
--
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades, and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture tablet products under the Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, Amway, Dabur, Future Group, Apollo Pharmacy, Sandika Pharma, Elder Pharma, JL Morisons, Aquawhite, 6 Ten Store, Modi Care, Infectiguard, and Odonil brands. It also provides contract manufacturing services for oral care products of other brands. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India.
www.svendgaard.com250
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: JHS.NS
View MorePerformance Overview: JHS.NS
Trailing total returns as of 5/28/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: JHS.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: JHS.NS
View MoreValuation Measures
Market Cap
1.23B
Enterprise Value
1.21B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.32
Price/Book (mrq)
0.67
Enterprise Value/Revenue
1.38
Enterprise Value/EBITDA
24.20
Financial Highlights
Profitability and Income Statement
Profit Margin
-28.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
890.97M
Net Income Avi to Common (ttm)
-249.43M
Diluted EPS (ttm)
-1.65
Balance Sheet and Cash Flow
Total Cash (mrq)
58.17M
Total Debt/Equity (mrq)
2.36%
Levered Free Cash Flow (ttm)
--